Alert: Major Price Advance (11/9/23)-Amphastar Pharmaceuticals Inc (NASDAQ: AMPH).


Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) stock closed at $52.41 on 11/9/23 after a major increase of 15.4%. The stock has been exceptionally strong relative to the market over the last nine months and has risen 15.3% during the last week.


Current PriceTarget Research Rating

Reflecting future returns on capital that are forecasted to be above the cost of capital, AMPH is expected to continue to be a major Value Builder.

Amphastar Pharmaceuticals has a current Value Trend Rating of C (High Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Amphastar Pharmaceuticals has a poor Appreciation Score of 28 but a very high Power Rating of 93, triggering the High Neutral Value Trend Rating.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.